Source - SMW
Mereo BioPharma said a US healthcare investor had bought a stake in the company for $3m.

The investor had bought around 12.3m shares at 18.8p each, a 20% discount to Mereo's closing share price on Tuesday.

Mereo said it would use the proceeds for general corporate purposes, including clinical trial activity and working capital.


At 8:41am: (LON:MPH) Mereo Biopharma Group Ltd share price was +0.5p at 24p



Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.